Is Tirzepatide legal in Norway?

Tirzepatide is among the peptides readers most often ask about in Norway. This page focuses on the regulatory reality there, not on how to obtain or use it, because that is where reliable, localized information is hardest to find.

In Norway, Tirzepatide has no marketing authorisation and is not an approved medicine anywhere in the world. It circulates online as a “research chemical” or “not for human use” product. That label does not make human use lawful or safe.

Importing Tirzepatide into Norway, including for personal use, is restricted, because it is an unauthorised medicine; customs may detain shipments. A “for research use only” label does not legalise import for human use. Personal possession of Tirzepatide in Norway sits in a grey area: it is not a scheduled controlled substance, so simple possession is generally not a drug-scheduling offence, but it is an unauthorised medicine and enforcement targets sale and supply.

Tirzepatide is named on the WADA Prohibited List as a growth-hormone secretagogue (section S2), so it is banned in sport at all times for competing athletes. That is an independent reason for caution regardless of local medicines law.

Selling or supplying Tirzepatide without the required authorisation is an offence in Norway. DMP (Norwegian Medical Products Agency, formerly Statens legemiddelverk) sets out the applicable sanctions; we do not reproduce specific figures here because they change. Confirm the current penalties with the regulator. This page reflects our reading of the position as of the last-verified date; regulations change, so confirm with DMP (Norwegian Medical Products Agency, formerly Statens legemiddelverk) before making any decision.